Table 1.
Patient characteristics
| Patient characteristics | Features | n (%) or median (range) | |
|---|---|---|---|
| Total number of patients | 46 | ||
| Sex | Male | 39 | |
| Female | 7 | ||
| Age | Years | 67 (44-83) | |
| Diagnosis | Esophagus | 17 (37) | |
| Esogastric junction | 12 (26) | ||
| Gastric | 13 (28) | ||
| Pancreatic | 4 (9) | ||
| Stage | I-III | 45 (98) | |
| IV | 1 (2) | ||
| Treatment characteristics | |||
| Chemotherapy | Sequential | Concomitant | |
| Total | 30 (65) | 16 (34) | |
| Platinum salts (CBDA/CDDP/OX) | 24 | 9 | |
| 5FU/Cape | 15 | 8 | |
| Taxanes (PTX) | 7 | 5 | |
| Other | 4 | 0 | |
| Radiation therapy | Total dose | 45 (25-56.6) Gy | |
| Dose/fraction | 1.8 Gy | ||
| Number of fractions | 25 (16-25) |
Abbreviations: 5FU = 5 fluorouracil; Cape = capecitabine; CBDA = carboplatin; CDDP = cisplatin; OX = oxaliplatin; PTX = paclitaxel.